Search

A recent study conducted by researchers at the Vellore Institute of Technology in Tamil Nadu, India, explores the concept of biographical renewal in cancer survivorship. The study highlights the positive transformations that can occur after cancer and emphasizes the importance of considering biographical renewal as a goal in survivorship care plans. The researchers suggest that healthcare professionals, caregivers, and palliative care providers should strive to foster an understanding of biographical renewal to provide comprehensive care and improve patients' quality of life. The study's findings are published in the Indian Journal of Palliative Care. [Extracted from the article]

Queen's University researchers have developed an educational resource for gynecological cancer survivors and their caregivers. The resource was created through a patient-clinician-researcher partnership and involved five phases, including assembling expertise, reviewing literature, drafting the resource, testing it, and disseminating it. The researchers used diverse partnerships and multiple research methods to create a resource that fills a procedural gap for clinicians and researchers looking to develop empirically and experientially founded educational resources. For more information, readers can refer to the article "Developing an educational resource for gynecological cancer survivors and their caregivers: A methods and experience paper" in the Canadian Oncology Nursing Journal. [Extracted from the article]

Acupath LABORATORIES INC., Biomarkers, Bladder Cancer, Business, Cancer, Cancer Biomarkers, Carcinoma Biomarkers, Cytology, Diagnostics and Screening, Health and Medicine, Oncology, Risk and Prevention Keywords: Acupath LABORATORIES INC.; Biomarkers; Bladder Cancer; Business; Cancer; Cancer Biomarkers; Carcinoma Biomarkers; Cytology; Diagnostics and Screening; Health and Medicine; Oncology; Risk and Prevention EN Acupath LABORATORIES INC. Biomarkers Bladder Cancer Business Cancer Cancer Biomarkers Carcinoma Biomarkers Cytology Diagnostics and Screening Health and Medicine Oncology Risk and Prevention 69 69 1 09/19/23 20230919 NES 230919 2023 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Acupath Labs released a white paper highlighting the impressive results of a large-scale internal study analyzing the clinical utility of its Acu-UR017 bladder cancer biomarker. [Extracted from the article]

Keywords for this news article include: Vienna, Austria, Europe, Allergies, Cancer, Health and Medicine, Immune System Diseases and Conditions, Immunology, Oncology, Risk and Prevention, University of Vienna. Keywords: Vienna; Austria; Europe; Allergies; Cancer; Health and Medicine; Immune System Diseases and Conditions; Immunology; Oncology; Risk and Prevention EN Vienna Austria Europe Allergies Cancer Health and Medicine Immune System Diseases and Conditions Immunology Oncology Risk and Prevention 981 981 1 10/30/23 20231031 NES 231031 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Immune System Diseases and Conditions - Allergies are discussed in a new report. [Extracted from the article]

Keywords: Antibiotics; Antineoplastics; Cancer; Cell Line; Doxorubicin Therapy; Drugs and Therapies; Health and Medicine; Oncology; Pharmaceuticals EN Antibiotics Antineoplastics Cancer Cell Line Doxorubicin Therapy Drugs and Therapies Health and Medicine Oncology Pharmaceuticals 69 69 1 03/23/23 20230314 NES 230314 2023 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on cancer are presented in a new report. The combination of doxorubicin, Baicalein, and resveratrol has resulted in a less cardiotoxic effect compared to treatment with doxorubicin alone." Conclusion: combinations of Baicalein and resveratrol with doxorubicin chemotherapeutic drug In Vitro had enhanced the cytotoxic activity of such a chemotherapeutic drug, while simultaneously eliminating its cardio-toxicity side effect.". [Extracted from the article]

Keywords for this news article include: Tianjin First Central Hospital, Tianjin, People's Republic of China, Asia, Cancer, Oncology, Health and Medicine. Keywords: Cancer; Health and Medicine; Oncology EN Cancer Health and Medicine Oncology 1114 1114 1 08/28/23 20230829 NES 230829 2023 AUG 29 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New study results on cancer have been published. [Extracted from the article]

Keywords: Cancer; Colorectal Research; Gastric Cancer; Gastroenterology; Health and Medicine; Oncology; Risk and Prevention EN Cancer Colorectal Research Gastric Cancer Gastroenterology Health and Medicine Oncology Risk and Prevention 961 961 1 06/26/23 20230627 NES 230627 2023 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New research on gastric cancer is the subject of a new report. Cancer, Colorectal Research, Gastric Cancer, Gastroenterology, Health and Medicine, Oncology, Risk and Prevention. [Extracted from the article]

Keywords: Wenzhou; People's Republic of China; Asia; Cancer; Diagnostics and Screening; Electronics; Gastric Cancer; Gastroenterology; Health and Medicine; Oncology; Optoelectronics EN Wenzhou People's Republic of China Asia Cancer Diagnostics and Screening Electronics Gastric Cancer Gastroenterology Health and Medicine Oncology Optoelectronics 561 561 1 06/05/23 20230606 NES 230606 2023 JUN 6 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on Oncology - Gastric Cancer are presented in a new report. Gas chromatography-mass spectroscopy (GC-MS) analysis of the exhaled gas from GC patients and healthy candidates indicated 25 different VOCs which may be used as the biomarkers.". [Extracted from the article]

Keywords: Karnataka; India; Asia; Biological Factors; Biological Tumor Markers; Biomarkers; Cancer; Cancer Biomarkers; Carcinoembryonic Antigen; Carcinoma Biomarkers; Cell Adhesion Molecules; Cell Research; Diagnostics and Screening; Emerging Technologies; Enolase; Enzymes and Coenzymes; Glycoproteins; Health and Medicine; Immunology; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Membrane Proteins; Nanotechnology; Neoplasm Antigens; Oncology; Physics; Quantum Dots; Quantum Physics; Tumor Markers EN Karnataka India Asia Biological Factors Biological Tumor Markers Biomarkers Cancer Cancer Biomarkers Carcinoembryonic Antigen Carcinoma Biomarkers Cell Adhesion Molecules Cell Research Diagnostics and Screening Emerging Technologies Enolase Enzymes and Coenzymes Glycoproteins Health and Medicine Immunology Lung Cancer Lung Diseases and Conditions Lung Neoplasms Membrane Proteins Nanotechnology Neoplasm Antigens Oncology Physics Quantum Dots Quantum Physics Tumor Markers 532 532 1 05/15/23 20230516 NES 230516 2023 MAY 16 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Diagnostics and Screening - Cancer Biomarkers have been published. According to the news editors, the research concluded: "This can become a promising diagnostic tool if extended for detection of other proteins or biomarkers involved in environmental and food safety research.". [Extracted from the article]

Biomarkers, Cancer, Diagnostics and Screening, Health and Medicine, Oncology Keywords: Biomarkers; Cancer; Diagnostics and Screening; Health and Medicine; Oncology EN Biomarkers Cancer Diagnostics and Screening Health and Medicine Oncology 1000 1000 1 04/03/23 20230404 NES 230404 2023 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on cancer is now available. [Extracted from the article]

Keywords: Cancer; Health and Medicine; Oncology; Prostate Cancer; Prostatic Neoplasms EN Cancer Health and Medicine Oncology Prostate Cancer Prostatic Neoplasms 111 111 1 03/23/23 20230321 NES 230321 2023 MAR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators discuss new findings in prostate cancer. Cancer, Health and Medicine, Oncology, Prostate Cancer, Prostatic Neoplasms. [Extracted from the article]

Cancer, Health and Medicine, Multicancer Early Detection Consortium, Oncology, Technology Keywords: Cancer; Health and Medicine; Multicancer Early Detection Consortium; Oncology; Technology EN Cancer Health and Medicine Multicancer Early Detection Consortium Oncology Technology 123 123 1 03/23/23 20230314 NES 230314 2023 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- When certain cancers are detected early, approximately 9 in 10 cancer patients will live five years or more, according to Cancer Research UK[1]. [Extracted from the article]

Keywords: Porto; Portugal; Europe; Biomarkers; Cancer; Diagnostics and Screening; Health and Medicine; Oncology EN Porto Portugal Europe Biomarkers Cancer Diagnostics and Screening Health and Medicine Oncology 2023 MAR 7 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on Cancer have been presented. Porto, Portugal, Europe, Biomarkers, Cancer, Diagnostics and Screening, Health and Medicine, Oncology. [Extracted from the article]

A recent preprint abstract highlights the issue of misidentified reagents in cancer research papers. The study found that a significant number of papers studying miR-145 had misidentified nucleotide sequence reagents and human cell lines. Additionally, the researchers discovered non-verifiable cell line identifiers that were not indexed in accessible repositories. This raises concerns about the reproducibility of research and calls for further investigation into the identities of these cell lines. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

A recent study conducted by researchers at the University of Campania in Naples, Italy, focused on the role of circulating microRNAs (c-miRNAs) in cancer research, specifically breast cancer (BC) and lung cancer (LC). The study analyzed over 150 papers published between 2018 and 2023, highlighting the effectiveness of c-miRNAs in areas such as early detection, therapeutic resistance, recurrence risk, and novel detection platforms. The researchers also examined the deregulated c-miRNAs shared between BC and LC papers, with a particular focus on miR-21 and miR-145. The study concludes that c-miRNAs in cancer research remain a significant topic of interest, with blood being the most investigated matrix. [Extracted from the article]

A recent report discusses research findings on cancer informatics, specifically focusing on significant contributions published in 2022. The research conducted an extensive search using PubMed/MEDLINE to identify the best papers in the field. The three selected best papers highlight advancements in federated learning, drug synergy prediction, and the utilization of clinical note data. The report concludes that cancer informatics is maturing as a subfield of biomedical informatics, with notable applications in data sharing and federated approaches. For more information, readers can refer to the Yearbook of Medical Informatics. [Extracted from the article]

A recent paper published in JCO Oncology Practice by bioethics researchers at the Dana-Farber Cancer Institute raises concerns about the ethical implications of patient-facing artificial intelligence (AI) in cancer care. While AI has the potential to improve access to care and enhance treatment outcomes, the authors emphasize the need to prevent depersonalization of patient care and erosion of patient-caregiver relationships. The paper highlights three areas where patients are likely to interact with AI: telehealth, remote monitoring, and health coaching. The authors call for collaboration among medical societies, government leaders, clinicians, and researchers to ensure that AI-driven healthcare upholds patient autonomy and respects human dignity. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the issue of intratumoral heterogeneity in tumor progression, which occurs when genetically distinct subclones emerge. These subclones are characterized by different types of somatic genomic aberrations, with single nucleotide variants (SNVs) and copy number aberrations (CNAs) being the most prominent. The paper introduces a method called DETOPT, which aims to accurately infer tumor progression trees by placing SNVs impacted by CNAs on these trees. The method is shown to provide more accurate tree placement of SNVs impacted by CNAs compared to existing alternatives. The paper also applies DETOPT to a set of tumor metastases from a treatment-refractory, triple-positive metastatic breast cancer, reporting biologically plausible trees of tumor progression. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

A scoping review conducted by researchers from Imperial College London examined the health inequalities that exist in access to, outcomes from, and experience of treatment for lung cancer. The review analyzed 41 papers and found that race, rural residence, and being part of a vulnerable or socially excluded group impacted access to lung cancer diagnosis, treatment, and supportive care. Additionally, rural residence, older age, and male sex negatively affected survival and mortality rates. The researchers concluded that these findings highlight the need for targeted efforts to improve equity in lung cancer care. [Extracted from the article]

Keywords: Cancer; Drug Resistance; Drugs and Therapies; Health and Medicine; Oncology EN Cancer Drug Resistance Drugs and Therapies Health and Medicine Oncology 814 814 1 10/16/23 20231017 NES 231017 2023 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on cancer. This paper details the changes of lipid metabolism in drug resistance and how lipid metabolism affects drug resistance. This paper summarizes the progress of drug design targeting lipid metabolism in improving drug resistance, and providing new ideas and strategies for future tumor treatment.". [Extracted from the article]

A new editorial paper published in Oncotarget discusses acute myeloid leukemia (AML), a type of aggressive cancer. The paper highlights recent advancements in understanding AML biology and the potential for developing novel drug therapies. The researchers suggest exploring reductive carboxylation as a possible drug target to weaken tumor cell survival mechanisms and improve patient outcomes. The paper provides further information on this topic and can be accessed through the provided DOI link. [Extracted from the article]

A recent editorial paper published in Oncotarget discusses the therapeutic potential and challenges of cytostatic persister cancer cells. These cells are able to remain viable despite treatment and can contribute to residual diseases and the emergence of resistant clones and relapses. Unlike resistant cells, persister cancer cells enter a non-proliferating state that is reversible upon treatment discontinuation. The paper highlights the need to understand the properties of cytostatic persisters and explores strategies for targeting them to reduce cancer recurrence. The researchers suggest that administering multiple targeted regimens may be necessary to effectively deplete the persister reservoirs in patients undergoing cancer treatments. [Extracted from the article]

A new study on non-small cell lung cancer (NSCLC) discusses the potential of liquid biopsy as an investigative approach for characterizing the disease. The study conducted a meta-analysis of 17 selected papers and found that liquid biopsy has a sensitivity of 0.59, specificity of 0.96, and diagnostic odds ratio of 24.69 in identifying EGFR mutations in NSCLC. However, the researchers note that the non-homogeneous literature data, lack of optimal detection methods, and relatively high costs currently make the applicability of liquid biopsy in routine diagnostics challenging. [Extracted from the article]

Researchers at the University of Turku in Finland conducted an integrative review to identify personal health-related resources for women with breast cancer. The review analyzed 23 peer-reviewed scientific papers published between January 2005 and May 2021. The researchers found that personal health-related resources for women with breast cancer can be categorized into three interconnected categories: personal strengths, person-centered cancer care, and social support from and involvement in their cultural community. The study concludes that nursing support is necessary to help women identify and utilize these resources, and further research is needed to improve measurement methods. [Extracted from the article]

A recent editorial paper published in Oncotarget discusses the molecular functions of regulatory genetic variants associated with cancer. The paper highlights the challenges in understanding the effects of genetic variants, such as their small effect size and their location in non-protein-coding regions of the genome. The researchers propose integrating genomic, epigenomic, transcriptomic, and machine learning methods to identify functional genetic variants and characterize their mode of action in regulating target genes. This approach has implications for cancer research and precision medicine. [Extracted from the article]

A recent study conducted by researchers at the First People's Hospital of Foshan examined the diagnostic efficacy of contrast-enhanced gastric ultrasonography in staging gastric cancer. The study analyzed multiple papers and found that both double contrast-enhanced gastric ultrasonography (D-CEGUS) and oral contrast-enhanced gastric ultrasonography (O-CEGUS) were effective in differentiating between T1 and T2 gastric cancer. The researchers concluded that O-CEGUS, due to its simplicity and cost-effectiveness, is often preferred as a staging method for gastric cancer before endoscopic intervention. This study provides valuable insights for clinicians in formulating treatment strategies for patients with early gastric cancer. [Extracted from the article]

A study published in JBMR Plus by Oxford University Press reveals that survival rates after hip or other bone fractures can be lower than those for many types of cancer. The study examined the post-fracture prognosis in people over 65 years using the database of the Ontario, Canada public healthcare system. The results showed that less than a third of men and half of women survived five years after a hip fracture, with overall survival rates being slightly better following vertebral fracture. The study emphasizes the need for doctors to intervene immediately after a fracture to improve patient prognoses. [Extracted from the article]

A recent study conducted by researchers at Shandong First Medical University and Shandong Academy of Medical Sciences has found that the G-protein signaling regulator 16 (RGS16) is associated with cancer, neurodegenerative diseases, and cardiovascular diseases. The study also revealed that RGS16 can be used as a biomarker for cancer diagnosis and prognosis. The researchers used data visualization analysis to examine 290 publications on RGS16 and found that the United States had the largest number of publications, with the Research Center of Allergy and Infectious Diseases (NIAID) publishing the most papers. The study concluded that RGS16 research is currently focused on various biological applications, including inflammation, cancer, ulcerative colitis, metabolic acidosis, platelet activation, and thrombosis. This research provides an overview of current and potential future research hotspots in the field of RGS16 and can be a valuable resource for interested researchers. [Extracted from the article]

A recent study conducted by researchers at Mayo Clinic in Rochester, Minnesota, examined the publication rates of radiation oncologists from highly ranked National Cancer Institute designated cancer centers. The study found that publication rates peak around 20 to 25 years into a career before declining. The number of authors listed per paper has also increased over time, which has an inflationary effect on authorships and h-index. However, the rate of manuscripts published per faculty has remained unchanged. This research provides valuable insights into the productivity and authorship patterns of radiation oncologists. [Extracted from the article]

Keywords: Cancer; Health and Medicine; Mouth Neoplasms; Oncology; Oral Cancer; Risk and Prevention; Smoking EN Cancer Health and Medicine Mouth Neoplasms Oncology Oral Cancer Risk and Prevention Smoking 918 918 1 10/09/23 20231010 NES 231010 2023 OCT 10 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Data detailed on oral cancer have been presented. Cancer, Health and Medicine, Mouth Neoplasms, Oncology, Oral Cancer, Risk and Prevention, Smoking. [Extracted from the article]

In a new paper, published in Scientific Data, researchers from the University of Illinois Urbana-Champaign have collected gene expression data in response to mechanical stiffness in tumors. Keywords: Cancer; Carl R. Woese Institute for Genomic Biology University of Illinois at Urbana-Champaign; Genetics; Health and Medicine; Oncology EN Cancer Carl R. Woese Institute for Genomic Biology University of Illinois at Urbana-Champaign Genetics Health and Medicine Oncology 634 634 1 10/03/23 20231003 NES 231003 2023 OCT 3 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Most solid tumors become stiff as the cancer progresses. Comparing 1 kPa to 40 kPa, which are similar to the pressure inside a solid tumor, showed differentially expressed genes and molecules that may be relevant for cancer progression", said You Jin Song, a graduate student of cell and developmental biology in the Prasanth lab. [Extracted from the article]